Screener
Repligen RGEN Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | 2%+2.7pp | 2.5%+3.8pp | 2.4%+3.9pp | 0.1%— | -0.7%— | |
| Liquidity | ||||||
| Current ratio | 9.1×+0.5× | 9.2×+2.4× | 8.4×0.0× | 8.4×-2.1× | 8.6×+1.9× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×+0.3× | 0.3×+0.2× | 0.3×0.0× | 0.3×+0.3× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $37.29+2.2% | $37.16+5.8% | —— | $36.85-99.9% | $36.48+3.8% | |
| Valuation | ||||||
| Market capitalization | $10.4B+24.3% | $6.64B-7.1% | $9.22B+14.4% | $7.52B-9.6% | $6.93B-1.5% | |
| Price / earnings | 250.4×-4,566× | 129.1×— | 188.6×— | 4,326.8×— | —— | |
| Price / book | 4.9×+0.9× | 3.2×-0.4× | 4.4×+0.3× | 3.6×-0.5× | 3.4×-0.2× |
FAQ
- What are Repligen's profit margins?
- Repligen (RGEN) runs a 47.6% gross margin and a 15.6% operating margin, with a 17.3% net margin.
- Where do Repligen's ratios come from?
- Every ratio is computed from Repligen's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
